Delivery Order SPE2DB20D2104-SPE2DB24FT63P
Award Date
4/16/24
Potential Completion Date
4/17/24
Potential Value
$2.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,106.98 fixed-price delivery order is for the drug Myrbetriq ER 50 mg tablets. The contract has an ultimate completion date of January 24, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued up to $999,999,999.00 through November 2026. The IDC enables the DLA to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $16,377.43 firm-fixed-price delivery order is for the supply of Myrbetriq ER 50 mg tablets. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $76,500.49 delivery order contract is for the supply of Myrbetriq ER 25 mg tablets. This award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. The IDC serves as the primary vehicle for Cencora, Inc. to deliver a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $26,730.25 for the supply of Myrbetriq ER 50 mg tablets to the Defense Logistics Agency (DLA). The contract has a ceiling value of $26,730.25 and an ultimate completion date of February 6, 2024. This award is not designated as a set-aside contract. The contract is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Myrbetriq ER 50 mg tablets. The contract has a ceiling value of $19,745.47 and a completion date of January 30, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The IDC enables the DLA to...
This federal contract award, with the ID SPE2DX15D3020|SPE2DX24FXKQW, is for the delivery of Myrbetriq ER 50 mg tablets to the Medical Supply Chain, a component of the Defense Logistics Agency (DLA). The $21,950.05 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on January 18, 2024, with a completion date of January 19, 2024. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora,...
This federal contract award, valued at $9,960.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of Myrbetriq ER 50 mg tablets, a pharmaceutical product, to support military and government healthcare programs. The contract is a Firm Fixed Price Delivery Order issued under a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Myrbetriq ER 25 mg tablets. The $2,250.23 firm-fixed-price delivery order falls under a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military...
This federal contract award, valued at $80,219.99, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Myrbetriq ER 50 mg tablets, a specialty medication. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC serves as the primary vehicle for Cencora, Inc....
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Myrbetriq ER 50 mg tablets with a ceiling value of $16,492.57 and a completion date of February 29, 2024. The contract is a firm fixed-price type with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...